Figure Gallery

Expression Pattern Search Results for myb

(467 figures with expression from 235 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Lam et al., 2009	Fig. 3	WT WT + MO7-runx1 WT + MO9-runx1	standard conditions standard conditions standard conditions	14-19 somites	intermediate cell mass of mesoderm
North et al., 2009	Fig. 1	WT tnnt2a^{unspecified/unspecified}	control chemical treatment: S-nitroso-N-acetyl-D-penicillamine chemical treatment: pharmaceutical	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 2	WT tnnt2a^{unspecified/unspecified}	standard conditions	Prim-25	ventral wall of dorsal aorta whole organism
	Fig. 4	WT tnnt2a^{unspecified/unspecified}	control chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO1-nos1 WT + MO1-nos2a WT + MO2-nos1 WT + MO2-nos2a	standard conditions standard conditions standard conditions standard conditions control chemical treatment: S-methyl-L-thiocitrulline chemical treatment: pharmaceutical chemical treatment: N-[3-(aminomethyl)benzyl]acetamidine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 3	WT	control chemical treatment: pharmaceutical chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Peterkin et al., 2009	Fig. 1	WT	control	10-13 somites	common myeloid progenitor
	Fig. 3	WT WT + MO1-sox32	standard conditions control	10-13 somites	anterior lateral plate mesoderm
van Rooijen et al., 2009	Fig. 3	WT vhl^hu2081/+; vhl^hu2117/+	standard conditions	Days 7-13	hematopoietic stem cell
	Fig. 4	WT vhl^hu2081/+; vhl^hu2117/+	standard conditions	Days 7-13	hematopoietic stem cell
Bertrand et al., 2008	Fig. 7	la2Tg	standard conditions	Day 4	hematopoietic stem cell
	Fig. 5	la2Tg; sd2Tg sd2Tg; zf71Tg	standard conditions	Prim-15 to High-pec	common myeloid progenitor hematopoietic stem cell intermediate cell mass of mesoderm ventral wall of dorsal aorta
	Fig. 1	WT	standard conditions	Prim-5 to Protruding-mouth	blood island common myeloid progenitor hematopoietic stem cell intermediate cell mass of mesoderm ventral wall of dorsal aorta
Imamura et al., 2008	Fig. 5	WT tp53^zdf1/zdf1 WT + MO1-tert tp53^zdf1/zdf1 + MO1-tert	standard conditions control	Long-pec	intermediate cell mass of mesoderm
	Fig. 3	WT WT + MO1-tert	standard conditions control	Prim-15	ventral wall of dorsal aorta
Kissa et al., 2008	Fig. S5	WT	standard conditions	Prim-25	blood cell ventral wall of dorsal aorta
Wei et al., 2008	Fig. 3	WT WT + MO1-gfi1aa	standard conditions control	5-9 somites	hematopoietic multipotent progenitor cell
Yeh et al., 2008	Fig. 5	WT	standard conditions	Prim-15	hematopoietic multipotent progenitor cell
Gardiner et al., 2007	Fig. 2	WT WT + MO2-klf17	standard conditions control	20-25 somites to Long-pec	whole organism
	Fig. 3	WT WT + MO2-klf17	standard conditions control	Prim-5	intermediate cell mass of mesoderm
Horsfield et al., 2007	Fig. S1	AB rad21a^nz171/nz171 (AB)	standard conditions	Prim-5	hematopoietic system
Jin et al., 2007	Fig. 1	y1Tg	standard conditions	Prim-15	ventral wall of dorsal aorta
	Fig. 3	y1Tg	standard conditions	Prim-15 to Day 5	hematopoietic system kidney ventral wall of dorsal aorta
	Fig. 6	y1Tg	standard conditions	Day 5	pronephros
McReynolds et al., 2007	Fig. 6	WT	standard conditions	Prim-5	intermediate cell mass of mesoderm